PATENT CLAIM ANALYSIS

Application Number: 16275165
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["560", "205000"]

Abstract:
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.

Claim (Index 18):
A method of treating a subject in need thereof, wherein the method comprises administering to the subject a pharmaceutically effective amount of a compound having the structure of Formula II: wherein the subject suffers from a disease or condition selected from narcolepsy, excessive daytime sleepiness, cataplexy, neurodegenerative disease, sleep disturbance syndrome, fibromyalgia, chronic fatigue, schizophrenia, binge eating disorder, Parkinson's disease, tardive dyskinesia, or Alzheimer's disease.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.06667
- Patent Class: 560.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15762559', '15095545', '14255331', '13372989', '13944354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.714407334794631
- 35 USC 102 Novelty (BERT): 0.5559087206083394
- Combined Prediction Score: 0.6985574733760018
- Mean Citation Score: 220.40382
- Max Citation Score: 306.43018
- Similarity Product: 233.1442464362955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test